| |
| |
|
| Insider
Information: |
Brady Todd C |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
1,628,586 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,784,033 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,628,586 |
|
|
| Total
Value |
$5,784,033 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
2
|
|
Stock
price went up :
|
1
|
2
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
2.0
|
| Percentage
Gain/Loss : |
 121.7%
|
52.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aldeyra Therapeutics, Inc. |
ALDX |
|
2024-03-12 |
1,471,298 |
|
0 |
Premium* |
|
|
Evoke Pharma Inc |
EVOK |
Director |
2014-09-23 |
4,000 |
2014-09-23 |
0 |
Premium* |
|
|
Outlook Therapeutics Inc |
OTLK |
|
2016-11-09 |
153,288 |
|
0 |
Premium* |
|
|
F-star Therapeutics, Inc |
FSTX |
Director |
2023-03-08 |
0 |
2016-11-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALDX |
Aldeyra Therapeutics, Inc... |
President and CEO |
• • – |
2024-03-12 |
4 |
S |
$3.05 |
$260,238 |
D/D |
(85,324) |
1,471,298 |
0 |
% |
|
| ALDX |
Aldeyra Therapeutics, Inc... |
President and CEO |
• • – |
2024-03-11 |
4 |
S |
$3.27 |
$320,521 |
D/D |
(97,914) |
1,556,622 |
0 |
% |
|
| ALDX |
Aldeyra Therapeutics, Inc... |
President and CEO |
• • – |
2023-09-07 |
4 |
D |
$7.22 |
$532,887 |
D/D |
(73,807) |
1,654,536 |
0 |
- |
|
| ALDX |
Aldeyra Therapeutics, Inc... |
President and CEO |
• • – |
2023-09-07 |
4 |
OE |
$0.55 |
$150,728 |
D/D |
273,058 |
1,728,343 |
0 |
- |
|
| FSTX |
F-star Therapeutics, Inc |
Director |
– • – |
2023-03-08 |
4 |
D |
$7.12 |
$106,828 |
D/D |
(15,004) |
0 |
0 |
- |
|
| ALDX |
Aldeyra Therapeutics, Inc... |
President and CEO |
• • – |
2023-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
238,750 |
1,455,285 |
0 |
- |
|
| ALDX |
Aldeyra Therapeutics, Inc... |
President and CEO |
• • – |
2022-06-23 |
4 |
B |
$3.36 |
$59,546 |
D/D |
17,700 |
1,216,535 |
2.81 |
% |
|
| ALDX |
Aldeyra Therapeutics, Inc... |
President and CEO |
• • – |
2022-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
250,000 |
1,198,835 |
0 |
- |
|
| ALDX |
Aldeyra Therapeutics, Inc... |
President and CEO |
• • – |
2021-04-12 |
4 |
A |
$0.00 |
$0 |
D/D |
46,619 |
948,835 |
0 |
- |
|
| FSTX |
F-star Therapeutics, Inc |
Director |
– • – |
2020-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
9,235 |
60,016 |
0 |
- |
|
| FSTX |
F-star Therapeutics, Inc |
Director |
– • – |
2020-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,418 |
50,781 |
0 |
- |
|
| FSTX |
F-star Therapeutics, Inc |
Director |
– • – |
2020-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
13,306 |
42,363 |
0 |
- |
|
| ALDX |
Aldeyra Therapeutics, Inc... |
President and CEO |
• • – |
2020-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
250,000 |
902,216 |
0 |
- |
|
| FSTX |
F-star Therapeutics, Inc |
Director |
– • – |
2019-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
7,832 |
29,057 |
0 |
- |
|
| ALDX |
Aldeyra Therapeutics, Inc... |
President and CEO |
• • – |
2019-12-16 |
4 |
B |
$5.10 |
$101,908 |
D/D |
20,000 |
652,216 |
2.81 |
- |
|
| ALDX |
Aldeyra Therapeutics, Inc... |
President and CEO |
• • – |
2019-09-30 |
4 |
AB |
$5.68 |
$49,483 |
D/D |
8,710 |
632,216 |
0 |
- |
|
| FSTX |
F-star Therapeutics, Inc |
Director |
– • – |
2019-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,597 |
21,225 |
0 |
- |
|
| ALDX |
Aldeyra Therapeutics, Inc... |
President and CEO |
• • – |
2019-09-23 |
4 |
AB |
$5.81 |
$50,433 |
D/D |
8,680 |
623,506 |
0 |
- |
|
| ALDX |
Aldeyra Therapeutics, Inc... |
President and CEO |
• • – |
2019-09-18 |
4 |
B |
$5.91 |
$84,465 |
D/D |
14,288 |
614,826 |
2.81 |
- |
|
| ALDX |
Aldeyra Therapeutics, Inc... |
President and CEO |
• • – |
2019-09-16 |
4/A |
B |
$6.03 |
$18,090 |
D/D |
3,000 |
600,538 |
2.81 |
- |
|
| ALDX |
Aldeyra Therapeutics, Inc... |
President and CEO |
• • – |
2019-09-16 |
4 |
B |
$6.03 |
$18,090 |
D/D |
3,000 |
591,991 |
2.81 |
- |
|
| ALDX |
Aldeyra Therapeutics, Inc... |
President and CEO |
• • – |
2019-09-13 |
4/A |
B |
$5.90 |
$109,359 |
D/D |
18,547 |
597,538 |
2.81 |
- |
|
| ALDX |
Aldeyra Therapeutics, Inc... |
President and CEO |
• • – |
2019-09-13 |
4 |
B |
$5.79 |
$57,900 |
D/D |
10,000 |
588,991 |
2.81 |
- |
|
| ALDX |
Aldeyra Therapeutics, Inc... |
President and CEO |
• • – |
2019-09-10 |
4 |
B |
$5.39 |
$53,937 |
D/D |
10,000 |
578,991 |
2.81 |
- |
|
| ALDX |
Aldeyra Therapeutics, Inc... |
President and CEO |
• • – |
2019-09-09 |
4 |
B |
$4.89 |
$48,887 |
D/D |
10,000 |
568,991 |
2.81 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
